Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the U.S. FDA has approved Restylane Contour for the correction of temple hollowing in patients over the age of 21.
Galderma, the pure-play dermatology category leader, today announced that the United States (US) Food and Drug Administration (FDA) has approved Restylane Lyft with Lidocaine for augmentation of the ...
Galderma receives US FDA approval for Restylane Contour for the correction of temple hollowing: Zug, Switzerland Tuesday, March 24, 2026, 18:00 Hrs [IST] Galderma, the pure-play d ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results